Innoviva (INVA) Share-based Compensation Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 19.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.56% |
| Sep 30, 2025 | 48.47% |
| Jun 30, 2025 | 47.41% |
| Mar 31, 2025 | 47.56% |
| Sep 30, 2024 | 11.17% |
| Jun 30, 2024 | 8.09% |
| Mar 31, 2024 | -8.95% |
| Sep 30, 2023 | -61.21% |
| Jun 30, 2023 | 12.59% |
| Mar 31, 2023 | 67.51% |
| Sep 30, 2022 | 585.79% |
| Jun 30, 2022 | 187.23% |
| Mar 31, 2022 | 111.53% |
| Sep 30, 2021 | 22.90% |
| Jun 30, 2021 | 25.33% |
| Mar 31, 2021 | 3.68% |
| Dec 31, 2020 | -8.40% |
| Sep 30, 2020 | -9.82% |
| Jun 30, 2020 | -20.89% |
| Mar 31, 2020 | -28.10% |
| Dec 31, 2019 | 0.41% |
| Sep 30, 2019 | 344.50% |
| Jun 30, 2019 | 159.25% |
| Mar 31, 2019 | -72.11% |
| Dec 31, 2018 | -79.98% |
| Sep 30, 2018 | -108.09% |
| Jun 30, 2018 | -132.96% |
| Mar 31, 2018 | -13.48% |
| Dec 31, 2017 | 29.51% |
| Sep 30, 2017 | 43.89% |
| Jun 30, 2017 | -14.57% |
| Mar 31, 2017 | 34.50% |
| Dec 31, 2016 | 13.58% |
| Sep 30, 2016 | 17.03% |
| Jun 30, 2016 | 55.93% |
| Mar 31, 2016 | -3.57% |
| Dec 31, 2015 | 19.83% |
| Sep 30, 2015 | -68.98% |
| Jun 30, 2015 | -76.48% |
| Mar 31, 2015 | -85.72% |
| Dec 31, 2014 | -76.98% |
| Sep 30, 2014 | -26.59% |
| Jun 30, 2014 | 8.17% |
| Mar 31, 2014 | 122.07% |
| Dec 31, 2013 | 4.25% |
| Sep 30, 2013 | 10.57% |
| Jun 30, 2013 | 19.79% |
| Mar 31, 2013 | -2.25% |
| Dec 31, 2012 | -7.58% |
| Sep 30, 2012 | -15.38% |
| Jun 30, 2012 | -4.72% |
| Mar 31, 2012 | 12.52% |
| Dec 31, 2011 | 32.32% |
| Sep 30, 2011 | 53.25% |